A Regulatory View on Adaptive/Flexible Clinical Trial Design

DOI10.1002/BIMJ.200610229zbMATH Open1442.62419OpenAlexW2161966436WikidataQ33999536 ScholiaQ33999536MaRDI QIDQ5122841

Author name not available (Why is that?)

Publication date: 24 September 2020

Published in: Biometrical Journal (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1002/bimj.200610229

zbMATH Keywords

non-inferioritystatistical informationstatistical efficiencysuperiorityadaptive information designdropping a treatment armregulatory evaluation

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Related Items (2)

Plan to be Flexible: A Commentary on Adaptive Designs ⋮ Challenges and regulatory experiences with non‐inferiority trial design without placebo arm

Recommendations

• Title not available (Why is that?) 👍 👎
• Adaptation in clinical development plans and adaptive clinical trial designs 👍 👎
• On the efficiency of adaptive designs for flexible interim decisions in clinical trials 👍 👎
• Adaptive Design Methods in Clinical Trials 👍 👎
• Adaptive and Flexible Clinical Trials 👍 👎
• Confirmatory Clinical Trials with an Adaptive Design 👍 👎
• Challenges in Implementing Adaptive Designs: Comments on the Viewpoints Expressed by Regulatory Statisticians 👍 👎
• A Consultant's Perspective on the Regulatory Hurdles to Adaptive Trials 👍 👎
• Some recent developments in the design of adaptive clinical trials 👍 👎

This page was built for publication: A Regulatory View on Adaptive/Flexible Clinical Trial Design

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5122841)